Cardiovascular Disease: Risk stratification in asymptomatic patients
The clinical usefulness of many novel risk factors or screening tests for cardiovascular disease remains unproven, particularly in asymptomatic patients. This article describes the rationale
for risk scoring and reviews some of the available means for refining risk stratification.
Skyscape offers Over 500 Medical Information Resources, including clinical & drug information, guidelines, journal summaries, clinical trials updates, on the platform of your choice-Palm, Windows Mobile, BlackBerry, iPhone, Laptop, Desktop & Tablet PCs.
CHANGE PROFILE
Modify your email address or make other changes to your account settings.
UNSUBSCRIBE
Remove your name from future product announcements and offers.
PRIVACY POLICY
Skyscape is committed to respecting your privacy.
This email was sent to: %%!contact_email%%. You are being sent this email because
you have registered to use a Skyscape product. Please add our email address to your
"safe list" so you can continue to receive product information and special offers.
Skyscape is a registered trademark. All trademarks are the property of their respective
owners. This email was sent by: %%!account_address%%